| Structure |
Chemical Name |
CAS |
MF |
 |
Latamoxef impurity B |
|
|
 |
3-メトキシモルフィナン-17-カルボアルデヒド |
28973-48-0 |
C18H23NO2 |
![3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide](/CAS/20210305/GIF/2511244-97-4.gif) |
3-(7,8-dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)-N-(((S)-3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)-N-methylpropan-1-amine oxide |
2511244-97-4 |
C27H36N2O6 |
 |
Labetalol EP Impurity I |
|
|
![Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-](/CAS/20210305/GIF/2443747-63-3.gif) |
Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-chloro-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl- |
2443747-63-3 |
C19H20BrClN6O4S |
 |
3-オキソ-1,2-ベンゾイソチアゾリン-2-酢酸メチルエステル1,1-ジオキシド(PIROXICAM IMPURITY D)ピルオキシカム不純物D |
6639-62-9 |
C10H9NO5S |
![(7S)-3-(ヒドロキシメチル)-7-[[(2-チエニル)アセチル]アミノ]-7-メトキシセファム-3-エン-4-カルボン酸](/CAS/GIF/54333-94-7.gif) |
(7S)-3-(ヒドロキシメチル)-7-[[(2-チエニル)アセチル]アミノ]-7-メトキシセファム-3-エン-4-カルボン酸 |
54333-94-7 |
C15H16N2O6S2 |
 |
ビス(ジメチルカルバミン酸)5-アセチル-1,3-フェニレン |
81732-48-1 |
C14H18N2O5 |
 |
Oseltamivir Impurity L |
|
|
 |
1,4-Naphthalenediol, 2-methyl-, 4-acetate |
110327-29-2 |
C13H12O3 |
 |
Oseltamivir Impurity 105 |
|
|
 |
Oseltamivir Impurity 77 |
|
|
 |
Imidapril Impurity 2 |
|
|
 |
11α,17,21-トリヒドロキシ-16β-メチルプレグナ-1,4-ジエン-3,20-ジオン |
85700-75-0 |
C22H30O5 |
 |
Crisaborole Impurity ABCDEFGHJKL |
|
|
![3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]-](/CAS/20210305/GIF/2474774-17-7.gif) |
3-Azetidinecarboxylic acid, 1-[(4-acetyl-2-ethylphenyl)methyl]- |
2474774-17-7 |
C15H19NO3 |
![2,3'-Bipyridine, 5-chloro-3-[4-(methylsulfonyl)phenyl]-, hydrochloride (1:1)](/CAS/20210111/GIF/202409-39-0.gif) |
2,3'-Bipyridine, 5-chloro-3-[4-(methylsulfonyl)phenyl]-, hydrochloride (1:1) |
202409-39-0 |
C17H14Cl2N2O2S |
 |
1,1'-((methylenebis(4-methoxy-3,1-phenylene))bis(2-(dimethylamino)ethane-1,1-diyl))dicyclohexanol |
|
|
 |
2-amino-4-(2-(benzyl(1-(4-methoxyphenyl)propan-2-yl)amino)-1-hydroxyethyl)phenol |
|
|
 |
Empagliflozin Impurity 116 |
|
|
![(3R,5aS)-5,8-dioxooctahydro-5H-pyrrolo[1,2-a]thiazolo[3,2-d]pyrazine-3-carboxylic acid](/) |
(3R,5aS)-5,8-dioxooctahydro-5H-pyrrolo[1,2-a]thiazolo[3,2-d]pyrazine-3-carboxylic acid |
|
|
 |
Phospholipid Impurity 1(DPPE-MPEG5000 Impurity 1) |
|
|
 |
Carbazochrome Sodium Sulfonate Impurity 4 |
|
|
 |
Empagliflozin Furanose Impurity |
|
|
 |
Rosuvastatin Impurity 144 |
|
|
 |
Cetrorelix Impurity 11 |
|
|
 |
Cetrorelix Impurity 4 (8-D-Arg) |
|
|
 |
Cetrorelix Impurity 1 (+L-Arg) |
|
|
 |
Peramivir Intermediate Impurity 36 |
|
|
 |
Peramivir Intermediate Impurity 41 |
|
|
 |
Peramivir Impurity 999 |
|
|
 |
Palonosetron impurity 20XH |
|
|
 |
Levofloxacin benzopazine impurity |
|
|
 |
Bumetanide Impurity 14 |
1431501-10-8 |
C21H27NO3 |
![Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride](/) |
Trans,rel-(1R,4R)-4-{[(2-Aminophenyl)methyl]amino}cyclohexan-1-ol Hydrochloride |
|
|
 |
Sugammadex Sodium Impurity 08 |
|
|
![2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](/) |
2-bromo-3-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |
|
|
 |
Org199425-1(RRT0.59) |
2412953-12-7 |
C72H112O49S8 |
 |
4a(2H)-Isoquinolinol, octahydro-4-(4-methoxyphenyl)-2-methyl- |
2568340-30-5 |
C17H25NO2 |
![3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-](/CAS/20210305/GIF/2468737-92-8.gif) |
3-Quinolinecarbonitrile, 4-[(2,4-dichloro-5-hydroxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]- |
2468737-92-8 |
C25H27Cl2N5O3 |
 |
Uridine, 4-oxime, 5'-(2-methylpropanoate), (4E)- |
2492423-30-8 |
C13H19N3O7 |
 |
Empagliflozin Furanose Impurity |
|
|
 |
Tazobactam Impurity XTE |
|
|
 |
Isavuconazole Impurity 46 |
|
|
 |
5-(1-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-2-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one |
2226428-25-5 |
C24H28N2O3 |
![3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, methyl ester, (αR,3R)-rel-](/CAS/20211123/GIF/2740235-22-5.gif) |
3-Pyrrolidinepropanoic acid, α-[[(1,1-dimethylethoxy)carbonyl]amino]-2-oxo-, methyl ester, (αR,3R)-rel- |
2740235-22-5 |
C13H22N2O5 |
![2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](/CAS/20181212/GIF/CB810019553.gif) |
2-(4-ethylpiperazin-1-yl)-4-(2-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |
|
C23H30FN3 |
 |
1-Naphthalenamine, 4-(2,3-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4S)-rel- |
2184053-08-3 |
C17H17Cl2N |
 |
Rosuvastatin Impurity 152 |
|
|
 |
1-(4-(2-(アゼパン-1-イル)エトキシ)ベンジル)-5-(ベンジルオキシ)-2-(4-(ベンジルオキシ)フェニル)-3-メチル-1H-インドール |
198480-21-6 |
C44H46N2O3 |
![6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5R,6E)-](/CAS/20210305/GIF/2273873-66-6.gif) |
6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, 1,1-dimethylethyl ester, (3S,5R,6E)- |
2273873-66-6 |
C29H32FNO4 |
 |
2H-1,4-Benzoxazin-3(4H)-one, 8-(2-chloro-1-hydroxyethyl)-6-(phenylmethoxy)- |
2383660-53-3 |
C17H16ClNO4 |
 |
Isavuconazole Impurity 40 |
|
|
 |
(2R,3S,4R,5R,6S)-2-((R)-1,2-dihydroxyethyl)-6-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)tetrahydro-2H-pyran-3,4,5-triol |
|
|
![2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide](/CAS/20210305/GIF/2724840-93-9.gif) |
2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-, 1,1'-dioxide |
2724840-93-9 |
C18H15ClN2O4S |
 |
Vitamin K1 Impurity C |
|
|
![4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-((5-methylpyridin-3-yl)methyl)piperidine 1-oxide](/) |
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-((5-methylpyridin-3-yl)methyl)piperidine 1-oxide |
|
|
 |
1-(4-Bromo-2-(hydroxymethyl)phenyl)-4-(dimethylamino)-1-(4-fluorophenyl)butan-1-olhydrochloride |
488148-10-3 |
C19H23BrFNO2 |
 |
Bisoprolol Impurity 42 |
|
|
 |
Peramivir Impurity 31(R) |
|
|
 |
Roxatidine Impurity 10 |
|
|
 |
2-methyl-4-(((2E,6E,10E)-3,7,11,15-tetramethylhexadeca-2,6,10,14-tetraen-1-yl)oxy)naphthalen-1-ol |
|
|
![2H-Pyrido[3,4-h]-1,4-benzoxazin-3(4H)-one, 7,8,9,10-tetrahydro-6,10-dihydroxy-8-[2-(4-methoxyphenyl)-1,1-dimethylethyl]-](/CAS/20210305/GIF/2727170-18-3.gif) |
2H-Pyrido[3,4-h]-1,4-benzoxazin-3(4H)-one, 7,8,9,10-tetrahydro-6,10-dihydroxy-8-[2-(4-methoxyphenyl)-1,1-dimethylethyl]- |
2727170-18-3 |
C22H26N2O5 |
 |
Vildagliptin Chloroacetyl Nitrile (R)-Isomer |
565452-98-4 |
C7H9ClN2O |
 |
Nirmatrelvir Impurity 5 |
|
|
 |
Brivaracetam Impurity 119 |
|
|
 |
Perospirone Impurity 27 |
|
|
 |
Paxlovid Impurity 11 |
|
|
 |
3-(2-(cyclopent-3-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
 |
Timolol maleate impurity 02 |
|
|
 |
Fondaparinux sodium impurity 19 |
|
|
 |
Lasmiditan Impurity 3 |
2941086-99-1 |
|
 |
Olaparib Adduct Impurity |
|
|
![8-chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b] pyridine](/) |
8-chloro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b] pyridine |
2514965-36-5 |
|
 |
Febuxostat impurity EOX |
|
|
 |
4-ヒドロキシ-2-メチル-3-メトキシカルボニル-2H-1,2-ベンゾチアジン1,1-ジオキシド |
35511-15-0 |
C11H11NO5S |
 |
Olodaterol Impurity 26 |
|
|
![2H-3-Benzazepin-2-one, 3-[3-[[(2S)-3-chloro-2-(3,4-dimethoxyphenyl)propyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-](/CAS/20211123/GIF/2768438-46-4.gif) |
2H-3-Benzazepin-2-one, 3-[3-[[(2S)-3-chloro-2-(3,4-dimethoxyphenyl)propyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy- |
2768438-46-4 |
C27H37ClN2O5 |
 |
Ethacridine Impurity 5 |
869002-00-6 |
|
 |
Olodaterol Impurity 29 |
|
|
 |
Elagolix Impurity 40 |
|
|
 |
8-chloro-6-fluoro-1-((1R,2S)-2-fluorocyclopropyl)-7-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid |
2365490-44-2 |
C13H8ClF2NO4 |
![[3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide](/CAS/GIF/106433-44-7.gif) |
[3-[[[2-(Diaminomethyleneamino)-4-thiazolyl]methyl]thio]propionyl]sulfamide |
106433-44-7 |
C8H14N6O3S3 |
 |
3-Formyl-25-desacetyl Rifamycin |
16783-97-4 |
C36H45NO12 |
![4-(3-メチルフェニル)-2H-ピリド[4,3-E]-1,2,4-チアジアジン-3(4H)-オン1,1-ジオキシド SODIUM SALT (TORSEMIDE IMPURITY)](/CAS/GIF/72810-61-8.gif) |
4-(3-メチルフェニル)-2H-ピリド[4,3-E]-1,2,4-チアジアジン-3(4H)-オン1,1-ジオキシド SODIUM SALT (TORSEMIDE IMPURITY) |
72810-61-8 |
C13H11N3O3S |
 |
8-Desacetyl-8-carboxy Daunorubicin Hydrochloride |
58199-96-5 |
C26H27NO11.ClH |
 |
D,L N,O-Didesmethylvenlafaxine |
135308-74-6 |
C15H23NO2 |
 |
Desmethyl Erlotinib Acetate |
183320-15-2 |
C23H23N3O5 |
 |
1',15-オキシエリスロマイシン |
41451-91-6 |
C37H65NO14 |
 |
3,4-ジヒドロキシベンゼンアセトアルデヒド |
5707-55-1 |
C8H8O3 |
 |
9-(2-プロペニル)アデニン |
4121-39-5 |
C8H9N5 |
 |
N-Methyl-N,N-bis(2-pyridylethyl)amine |
5452-87-9 |
C15H19N3 |
 |
Benazepril Related Compound F |
|
|
![1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-trans)-](/CAS/GIF/111188-70-6.gif) |
1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-trans)- |
111188-70-6 |
C22H26N2O4S |
 |
1H-Benzimidazole-2-sulfinicacid(9CI) |
58536-71-3 |
C7H6N2O2S |
 |
3-メチルフタリド |
3453-64-3 |
C9H8O2 |
 |
4-hydroxyurapidil |
88733-12-4 |
C20H29N5O4 |
 |
desisopropylprocaterol |
63483-95-4 |
C13H16N2O3 |
 |
10-ブロモカルバマゼピン |
59690-97-0 |
C15H11BrN2O |
 |
(-)-アポビンカミン酸エチル |
42971-12-0 |
C22H26N2O2 |